John P. Saharek - Mar 1, 2024 Form 4 Insider Report for HARROW, INC. (HROW)

Role
CEO of ImprimisRx
Signature
/s/ John P. Saharek
Stock symbol
HROW
Transactions as of
Mar 1, 2024
Transactions value $
$43,750
Form type
4
Date filed
3/6/2024, 06:06 AM
Previous filing
Feb 21, 2024
Next filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common stock Options Exercise $43.8K +5K +2% $8.75 255K Mar 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HROW Stock Option (Right to Buy) Options Exercise $0 -5K -100% $0.00* 0 Mar 1, 2024 Common Stock 5K $8.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024.